In addition to being part of the classical third component of complement, /31c-globulin (1) has been shown to play a key role in the mechanism of immune adherence (2), conglutination, immune conglutination (3), and erythrophagocytosis in vitro (4) and in vivo (5).
~UNE HEMOLYSIS

Materials and Methods
Purified Human Complement Components.--The method of isolation of the fourth component of complement (C'4), or ~l~.-globulin, was described previously (13) . The preparations of C'4 used in this study were homogeneous upon starch gel and immunoelectrophoresis. As a further check of molecular homogeneity, samples of each batch were tested for susceptibility to the action of C'I esterase (kindly supplied by Dr. Irwin Lepow, Cleveland) . In each instance, the protein underwent complete conversion to the characteristic inactive reaction products which are distinguished from the native protein by a different mobility on starch gel electrophoresis (14) . Cr3 was isolated according to a recently published method (6) by which the protein can be obtained free of C~5, C'6, and ~m-globulin. The preparations used were homogeneous by the criteria of starch gel electrophoresis and immunoelectrophoresis, all of the protein being present in the electrophoretically slow, hemolytically active form.
The second component of complement (C'2) was obtained according to a method to be published in full elsewhere (15 b) . For the purpose of this study it was thought sufficient to use preparations that were 5000-to 7000-fold purified, as compared to serum and that contained approximately 25 to 30% C'2 in terms of total protein. These preparations were free of other complement components and were contaminated primarily with ~lA-globulin. They were obtained by chromatography on carboxymethyl cellulose followed by electrophoresis on Pevikon blocks. Throughout the procedure of isolation, phosphate buffer pH 6.0, T/2 ---0.05, was used which contained 0.005 ~ EDTA.
To enhance CP2 activity, some of the preparations were treated with iodoacetamide (0.05 ~¢) at pH 6 and at a maximalprotein concentrationof 100/~g/ml, as described previously (15 a, 16) . This resulted in a 7-to 10-fold increase in apparent Cr2 hemolytic activity.
Labeling of C~3 and C4 with Radioactive lodine.--Many different batches of both proteins
were successfully labeled with iodine-131 (I TM) or iodine-125 (1125) according to a method described by McConahey and Dixon (17) . 500/zc of either I TM or 1 l*s were addedin carrier-free form without preservatives or reducing substances to 2 mg of protein in 4 ml ice cold veronalsodium chloride bufferpH 7.3. While the protein-iodine mixture was stirred, 100/zg of chloramine T(200/zg/ml solution in distilled water) was added and allowed to react for 5 min. The oxidizing agent was then neutralized by the addition of 100/zg sodium meta bisuifite. To remove unbound iodine, the iodinated protein was dialyzed for 24 hr against 3 X 10 liters of veronal--sodium chloride buffer. Iodine uptake varied between 60 and 80o'/0, the specific radioactivity of labeled C~4 between 3 X 104 and 4 X lif t cP~//~g, and the specific radioactivity of labeled C~3 between 5 X 104 and 7 )< 104 cP~r//zg. The procedure of labeling had no effect on the hemolytic activity of C~3 and in most instances no effect on Cr4. For unknown reasons, the hemolytic activity of two batches of C~4 was reduced to one-third of the original value after iodination. These batches were not used for this study. For experiments in which C~3 was used in high concentrations, the specific radioactivity of this protein was reduced to 3 to 10 X 10 a cP~/#g by mixing labeled with unlabeled C~3.
Preparation of Sheep Erythrocyte-Complement Complexes with Radioactively Labeled and Unlabeled Complement Components.--EAC'la,4, the complex consisting of sheep erythrocytes
(E), rabbit antibody to sheep erythrocytes (A), the activated first component of complement (Cqa) and C'4, was prepared in the following way. EA was incubated with the chromatographically separated subcomponents of the first component, Cqq, Cqr and C'ls, as described by Lepow et at. (18) . This resulted in formation of the complex EAC'la. Since C'lr was contaminated with C~4, this fraction was treated before use with 0.02 ~ hydrazine at 37°C for 45 rain. While C~4 was thus inactivated, C'lr activity remained unimpaired. 10 ml of a 2.5% suspension of EACqa was then incubated with 4.5 to 80/zg of purified C'4 at 37°C for 30 min. The ceils were washed twice before use.
When EAC'la,4 was made using I m-or IX2~-labeled C'4, the procedure was slightly modified. Human serum albumin (Behringwerke "reinst") was added in substance to the solution of labeled C'4 to yield an albumin concentration of 2%. The labeled protein was thereby prevented from forming small amounts of precipitate in the course of being pipetted. Even a minute amount of radioactive precipitate in the reaction mixture constitutes a large source of error causing falsely high values for cellular Cr4-uptake. The albumin-Ct4 solution was therefore centrifuged before use at 1300 X g for 20 rain.
To minimize nonspecific adsorption of radioactively labeled Ct4 to the erythrocyte surface, the cells were incubated, after sensitization with antibody, with KBr-treated serum. To 20 ml of a 2.5% suspension of EA containing 0.01 M EDTA, 0.5 ml of KBr-treated serum was added and the mixture left at 4°C for 1 hr, whereupon the cells were washed twice, once in 0.01 M EDTA containing veronal buffer and once in Ca +4 and Mg ++ containing veronal buffer. As will be pointed out below, KBr-treated serum contains C'3 and C'4 in hemolytically inactive form. This measure reduced nonspecific cellular adsorption of radioactive C'4 and C'3 from more than 14 to less than 1%. Table I lists the number of C'4 molecules taken up per cell as a function of C'4 input into the reaction mixture. The total reaction volume was 4 ml, the number of cells 9.2 × 10 s, and the time at 32°C 30 rain. Specific uptake was ascertained as described below.
In some instances, EACqa,4 cells were obtained by decay of EACqa,4,2a cells at 37°C for 90 rain.
EAC'la,4,2a ceils were prepared by incubating EACtla,4 cells at 32°C for a predetermined period of time (tm~=) with an excess of purified C~2 or with iodoaeetamide-treated C'2. The half-life of this complex at 32°C was 10 rain when untreated C'2 was used and approximately 150 rain when CP2 was first treated with iodoacetamide (15a, 16).
Alternatively, EAC'la,4,2a cells were prepared with whole human serum in the presence of phloridzin. 30 ml of a 2.5% suspension of EA was mixed at 37°C with a solution of 320 mg phloridzin in 30 ml of isotonic veronal buffer. Phloridzin was dissolved by miring the temperature briefly to 70°C. 2 ml of human serum was then added to the phloridzin contaiuing cell suspension. After exactly 1.5 rain at 37°C, the mixture was poured into 140 ml of ice cold isotonic veronal buffer and centrifuged at 0°C. The cells were washed once before use. Tested with 1:20 dilution of human serum in the presence of 0.01 ~ EDTA, these cells usually lysed completely within 10 to 15 rain. They were free of significant amounts of C'3, as evidenced by negative immune adherence and negative agglutination with an antiserum to C'3.
EAC 'la,4,2a,3. --This complex was made by treating EACtla,4,2a cells with purified C'3 at 32°C for 5 to 30 rain in veronal buffer pH 7.3. Since 90 to 95% of the C'3 input is found after the reaction in the fluid phase as hemolytically inactive, converted C'3, the input should exceed the desired uptake 10-to 20-fold. Formation of this intermediate complex was tested with a 1:20 dilution of KBr-treated human serum in the presence of 0.01 x¢ EDTA.
When radioactively labeled C'3 was used, the same measures were employed that were described above for the use of radioactively labeled C'4.
Other erythrocyte-complement complexes utilized in this study were EC'4, ECt4,2a, and EC'4,2a,A. Technical details of the formation of EC'4 were described previously (14) . The complex ECI4,2a was made by incubating 2 ml of a 7.5% suspension of EC~4 cells with an excess of iodoacetamide-treated, purified C'2 and 0.25 units of CJ1 esterase for 30 to 40 rain at 32°C. The total reaction volume was 2.5 ml. After incubation the cells were washed twice with ice cold verona] buffer. In one experiment, EC'4,2a cells were sensitized with 8 units of anti-sheep erythrocyte antibody to yield EC~4,2a,A cells. Source of the antibody was a 19S fraction which was isolated from a rabbit antiserum by sucrose density gradient ultracentrifugation in phosphate buffer pH 7, T/2 = 0.1.
Quantitation of C'3-and C~4-Uptake by Erythrocytes.--For quantitation of cellular uptake, radioactively labeled components were used. If uptake of both C'3 and C~4 was measured in the same experiment, a differential radioactive label was employed. All determinations of Cr3 -or Ct4-uptake were performed in two different sets of reaction mixtures, one containing optimal amounts of Ca -~" and Mg ++ and the other 0.01 ~ EDTA. The latter set yielded values for nonspecific attachment due to adsorption and not due to the action of the complement system. To obtain the value for specific uptake of Cr3 or CP4, the value for uptake observed in the presence of EDTA was subtracted from that measured when Ca ++ and Mg ++ were present. For computing the number of molecules per cell, a molecular weight of 300,000 was assumed for both CP3 and Cr4, since their s rates are 9.5S and 10.0S, respectively. The s rates were essentially unchanged after dissociation of the two components from complementtreated erythrocytes (19) . The number of C~3 molecules per C'4,2a site was calculated by determining the molar ratio of Cr3 to C~4 on the cell surface. This method yields a minimal estimate, since it is not known whether all C'4 sites were in association with an activated Ct2 molecule while the interaction between the cells and Cr3 occurred.
Quantltatlon of Converted Cr3 in the Fluid Phase.--This again was done using radioactively labeled C'3. After the reaction was stopped by centrifugation of the reaction mixtures at 0°C, suitable samples of the cell-free supernatants were analyzed by immunoelectrophoresis. Mter 2.5 hr of electrophoresis at 6 v/cm, the patterns were developed with a specific antiserum to Reaction volume, 4 ml; number of ceils, 9.2 X 10s; time at 32°C, 30 rain.
C'3. 15 hours later the gel was cut into segments such that the C'3-(or ~m) precipitin line and the C~3i -(or ~IG) fine (7, 26) were located in different segments. The radioactivity in each segment was then counted and the counts obtained on the C'3i-segment were expressed in per cent of total number of counts (C'3 plus C'3i). Controls included the original C'3 material that had not been reacted with cells and C~3 that had been incubated with cells which, however, did not contain activated C'2. lmmune Adkerenee.--The method of Nishioka and Linscott (2) was adopted. The EACqa,4,2a,3 complex was assembled stepwise as described above using radioactively labeled C~3. Immediately after the cells were prepared, one portion was used for the immune adherence test and another portion was set aside for quantitation of bound radioactive C'3.
Incorporation of Radioactively Labeled C'3 and C~4 into Human Serum.--One part of saturated aqueous solution of KBr was added to one part of human serum and the mixture was kept at 4°C overnight. KBr was then removed by thorough dialysis against phosphate-buffered saline. As will be reported elsewhere (20) , this treatment resulted in selective inactivation of CI3 and Ct4 and concomitant physicochemical changes of these two proteins. In addition Ct5 activity was reduced by approximately 30%. Hemolytic activity is virtually restored by addition of purified ct3 and Ct4. For several experiments, KBr-treated serum wasreconsfituted by addition of 30 to 580 ~g of radioactively labeled Ct3 and of 10 to 90 #g of radioactively labeled Ct4. The normal serum concentration of C~3 and C~4 is estimated to be approximately 500 ~g/ml and 40 to 60 tzg/ml, respectively.
Quantitation of Hemolysis as a Function of C~3 Uptake.--The reaction mixtures consisted of 8 to 10 X l0 s EA and 1:40 KBr-treated serum which was reconstituted with respect to Ct3 and C'4. Either C'3 alone or C'3 and Ct4 were labeled with radioactive iodine. The total reaction volume was 4 ml and the reaction time at 32°C varied between 18 and 60 min. Controls contained 0.01 ~ EDTA instead of optimal amounts of Ca ++ and Mg++. The reaction was terminated by transfer oi the reaction tubes to a 0°C alcohol bath. Immediately thereafter, 1 ml aliquots were withdrawn for determination of the degree of hemolysis. The remaining 3 ml were diluted with 27 ml of ice cold veronal buffer and subjected to centrifugation at 25,000 RPM. and I°C for 30 rain in a Spinco L2 ultracentrifuge using a No. 30 rotor. The sediments consisting of unlysed cells and cell ghosts were washed twice by resuspension in 30 ml veronal buffer and ultracentrifugation before their radioactivity was determined. In some experiments highly purified CI5 was added in excess to the reaction mixture.
Other Methods.--Sucrose density gradient ultracentrifugation was performed according to Kunkel (21) and immunoelectrophoresis according to Scheidegger (22) .
FIG. 1. Immunoelectrophoretic demonstration of the conversion of highly purified Cr3
to CI3i by EAC'la,4,2a cells. Upper pattern, C'3 after incubation at 37°C for 15 min with EAC'la,4,2a. Lower pattern, Ct3 after incubation under the same condition with EACrla,4 Anode was at the right; pattern was developed with rabbit anti-C'3.
RESULTS
The Immediate Reaction Product of C'3.--It was previously reported that CP3 undergoes changes in physicochemical and immunologic properties when participating in the interaction of complement with antigen-antibody complexes. These observations were made on C'3 in whole human (23) and mouse (24) serum, and in guinea pig euglobulin (25) . The presence of a large number of other serum constituents hindered thorough analysis of the reaction product and did not allow precise definition of the complement factors which govern the C'3 reaction step.
The behavior of CP3 was, therefore, studied in reaction mixtures consisting only of highly purified Ct3 and of defined erythrocyte-complement complexes. Fig. 1 shows an immunoelectrophoretic analysis of C'3 after a short period of incubation at 37°C with EAC~la,4 and EACqa,4,2a. The protein was converted to a more rapidly migrating form by cells containing activated C~2 on their surface (EACqa,4,2a), but not by cells lacking this component (EAC'la,4).
Ultracentrifugal analysis in a sucrose density gradient revealed that the sedimentation velocity of converted C'3 is very similar to, although not identical with, that of native C'3 ( Fig. 2) . In four different experiments it was found to be approximately 9S, the s rates of native C'3 and "aged" C'3 (flEe-globulin) being 9.5S and 6.9S, respectively (1). Several ultracentrifugal experiments were performed with Ilal-labeled C~3 to facilitate detection of low molecular weight split products which might arise in the process of conversion. As seen in Fig. 2 , a slowly sedimenting, radioactively labeled component could not be detected after conversion.
Freshly converted Ct3 was tested for hemolytic activity and compared with identical amounts of the native protein. The results, which are listed in Table  II, show that converted C'3 is totally inactive. In the following it will, therefore, be referred to as C'3i instead of "~m", an immunoelectrophoretic term used previously (7, 26) .
Ouchterlony plate and immunoelectrophoretic analysis of Ct3i showed it to be antigenically deficient when compared with native C'3. The precipitin line of the latter spurred over that of Ct3i. In this respect, C~3i resembles ~IA-globulin, the previously described product of aging. However, the s-rate of C~3i indicates that it is distinct from fl~-globulin and that conversion of C'3 to C~3i involves a relatively subtle change of the molecule, the chemical nature of which is presently being investigated. 
The Complement Factor Which Governs the C~3 Reaction
Step.--The C~3 reaction step of human complement involves both conversion of C'3 to C'3i and attachment of the protein to antigen-antibody complexes or cell membranes (7) . As demonstrated in Fig. 1 , conversion requires the presence of Ct2a, a fact which was also recognized by Pondman and Peetoom (27) . Similarly, uptake of Ct3 by cells was found to be dependent upon C~2a. This is illustrated in Fig. 3 , which depicts the results of an experiment in which the initial concentration of Ct3 was large as compared to the amounts of C~2 used. Under these conditions, a linear relationship was observed between uptake of C~3 by EAC~la,4 cells and the concentration of C~2 in the reaction mixture. Since C~2 reacts with Number of EAC'la, 4, 2a, 8.6 X 10s; initial C'3 concentration, 820 #g/ml; time at 32°C, 30 rain. EAC'la,4 to yield EACqa, 4,2a, it follows that the extent of C'3 attachment is determined by the number of available Ct4,2a sites per cell.
The relation between uptake and conversion was studied by quantitafing both reactions simultaneously. This was done in a set of reaction mixtures which were identical with respect to the absolute number of cells and the initial C'3 concentration, but which differed with respect to reaction volume and, hence, cell concentration. The results are listed in Table HI . Most of the C'3 which was turned-over by the EAC'la, 4, 2a cells was found as C'3i in the fluid phase and only 10 to 14 % was bound to the cells. While the ratio of uptake to conversion varied somewhat with the size of the reaction volume, uptake remained small as compared to conversion.
C'3 Uptake as a Function of Time, pH, Temperature, and C'3 Concentration.-To characterize further C'3 binding, the reaction was studied under a variety of different experimental conditions. The velocity of the reaction was estimated in a number of kinetic experiments in which EAC'la,4, 2a cells were incubated with C'3 11.~ at 37°C and pH 7. experiments, the cell concentration was chosen to be 25 % and the initial C"3 concentration 1.2 X 106 molecules per cell. As seen in Fig. 4 , the reaction started without lag and proceeded rapidly resulting in the binding of 1.35 X 105 C'3 molecules per cell in the first minute. EACtla,4 cells subjected to the same conditions did not bind significant amounts of C'3.
The effect of pH on C'3 binding is illustrated in Fig. S . Isotonic phosphate buffers were used and the pH was varied between 5.6 and 7.9. The pH optimum was found between pH 6 and pH 7.
The effect of temperature on C'3 binding is depicted in Fig. 6 . The reaction was carried out at pH 7.3 in isotonic NaC1 veronal buffer, i.e., under conditions conventionally employed for the quanfitafion of hemolytic complement. The reaction proceeded maximally at a temperature of approximately 32°C and stopped at 0°C.
The influence of the initial C'3 concentration on the rate of binding was m~VNE m~oLYsls investigated next and the result is shown in Fig. 7 . The C'3 concentration was varied between 0.6 × 104 and 2 × 10 ~ molecules per cell. In this concentration range the reaction proceeded according to first order kinetics. The kinetics of the C'3 binding reaction as well as its temperature-and pH-dependence suggest that it is enzymatic in nature. Inhibition of C~3 Uptake.--In view of the probable enzymatic nature of the C~3 binding reaction, several amino acid derivatives and other agents were tested for inhibitory activity. The following substances lacked inhibitory activity at the concentration tested; p-tosyl-L-arginine methyl ester (1.3 X 10 -2 ~), benzoyl-glycine methyl ester (1.3 X 10-2~), IAysine methyl ester (1.3 X 10 -2 ra), ,-amino-N-caproic acid (1.3 X 10 -2 ~t), diisopropylfluorophosphate (10 --4 ~r), iodoacetamide (2.7 X 10 -2 ~r). By contrast, phloridzin exerted a marked inhibitory effect (Table IV) . This substance had previously been pointed out as a complement inhibitor, interfering with the classical third component (28) . Since phloridzin did not inhibit C'3 conversion, it is improbable that it interfered with C'2a activity. Instead, it probably exerted its effect by blocking C~3 receptor sites on the cell surface. Conditions: 109 EAC'la, 4, 2a; 50/zg C'3 1131; volume, 4 ml; 5 rain at 32°C.
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C'3 Binding Capacity of a Single C~4,2a-Site on the Cell
Surface.--If specific binding of CP3 was simply due to adsorption, only one or a very few molecules of the protein would be expected to be bound by a single C~4,2a site. If, however, C~4,2a functioned as an enzyme catalyzing uptake of C~3 by cell membrane receptors, the number of molecules bound per site might be much larger. To distinguish between the two possibilities, the C~3-C~4 ratio was determined for cells in the state EACqa, 4,2a, 3. To this end, EACqa, 4 cells were prepared which contained a known number of C~4 molecules per cell using C~4-I m. They were then incubated with C'3-I ~5 in the presence of an excess of iodoacetamidetreated C~2. Fig. 8 shows the molecular ratio of cell-bound C~3 and Cr4 as a function of the initial Ct3 concentration in the reaction mixture. It is obvious that a single C'4, 2a site can be instrumental in the binding of many, i.e., several hundred C'3 molecules.
The Nature of the C'3 Receptor.--The fact that as many as several hundred C'3 molecules can become cell-bound through the action of a single Cr4,2a-site, precludes the possibility that the Ct4,2a site itself functions as C'3 acceptor. Such a large number of macromolecules could not attach themselves to a bimolecular complex roughly equal in size to one C'3 molecule. This leaves as probable sites of attachment the antibody molecules coating the cell surface and the cell membrane itself; C'I can be ruled out because it can be detached from EAC'la,4,2a cells without impairing their reactivity with C'3 (29) .
To determine whether antibody is essential for C'3 binding to cells, erythrocyte-C'4,2a complexes were prepared which were entirely devoid of antibody (30 b). As shown in Table V, FIc. 8. C'3 binding capacity of a single C'4,2a-site on EACqa,4,2a cells determined for various initial concentrations of C'3 in the reaction mixture. The reaction was performed at 32°C for 40 rain using 4.9 X l0 s cells in 3 ml total reaction volume, each cell carrying on its surface an average of 138 C'4 molecules. C'2 was used in iodoacetamide-treated form and C'3 was labeled with I LeS.
anti-sheep erythrocyte antibody (EC'4,2a, A). It is, therefore, concluded that binding of Cr3 occurs directly to cell membrane constituents and that antibody plays no essential role in this reaction. The above observation does not preclude, however, the possible occurrence of C'3-anfibody complexes. Attention is drawn to the fact, also shown in Table V , that C'3 which was bound by EC'4,2a in the absence of antibody was potentially cytolytic. Together with other terminal complement factors it caused lysis of the cells by which it was carried.
It was shown previously (14) that C'4 can be attached to E by the action of C'I esterase present in the fluid phase. It appeared possible that in an analogous fashion C'3 might be bound to E, EA, or EC'4 by fluid phase C'4,2a complex. This, however, was not observed (Table V) . The possible significance of this observation will be discussed below. Preparation and properties of the C'4,2a complex in cell-free solution will be described elsewhere (30 b) .
The Functional Significance of Cell-Bound C'3.--As demonstrated above, EAC'la,4,2a cells, due to the action of their C'4,2a sites, have the capacity to bind a large number of C'3 molecules. The question arose, therefore, whether Sheep erythrocytes containing on their surface known numbers of C'3 molecules were tested for their immune adherence capacity. Cells with an average of 510 or more bound C'3 molecules gave a positive reaction, while ceils containing 170 bound C'3 molecules were negative, even when tested at a cell concentration of 2.5 % (Table VI) . Thus, the critical number of molecules per cell which led to a detectable reaction was somewhere between 170 and 510, while a reaction of maximal intensity required several thousand bound C'3 molecules per cell.
The requirement of C'3 in immune hemolysis was investigated next and the data are summarized in Table VII . In this experiment the degree of hemolysis achieved was compared with the amount of Ct3 incorporated into the reaction 
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I~cules/cell C~ %40- KBr-treated serum was used as a source of all complement components, except C'3 and C~4; these two components were supplied in radioactively labeled form. While the amount of C'3 was varied, all reaction mixtures received an equal amount of C'4 which provided 1020 bound molecules per cell. Iodoacetamide-treated, purified C'2 was added to assure an excess of this component in all samples. The values of C'3 uptake recorded in Table VII represent specific binding; nonspecific binding was less than 1%.
Hemolysis increased with the amount of C'3 input and with the number of cell-bound C'3 molecules. At 64% lysis the average number of C'3 molecules bound per cell was 5600. Addition of an excess of purified C'5 (6) FIO. 10 . Reciprocal relation between the amounts of cell-bound C'3 and C'4 in hemolysis; shown for 12, 18, and 23% lysis of 9.2 X 10 s cells. The reaction was carried out at 32°C for 40 mill using radioactively labeled C'3 and C% KBr-treated serum (1:40) and iodoacetamidetreated C'2 in a total volume of 4 ml.
between lysis and C'3 binding was revealed when the hemolysis data listed in Table VII were expressed according to Mayer (12, 31) in terms of "average number of hits per cell". It is inferred from these observations that the molecular multiplicity occurring at the C'3 step of the complement reaction is functionally relevant with respect to immune adherence and the cytolytic effect of complement.
Reciprocal Relationship Between C'3 and C'4 Requirement in Immune Hemolysis.--The final question pursued in this study was whether a given degree of hemolysis corresponds to a characteristic number of bound C'3 molecules per cell. It was found that this number was variable in that it was inversely proportional to the number of cell-bound C'4,2a sites. For example, 23 % hemolysis was achieved with 1333 bound C'3 molecules and 1020 bound C'4 molecules per cell. At the same level of lysis, 5500 bound C~3 molecules per cell were required when these cells contained only 154 bound C~4 molecules each. Fig. 9 shows the quantitative relation between hemolysis and the ratio of bound C~3 and C~4. Three different cell batches were used, each differing in the number of bound C~4 molecules per cell. Again, this experiment was performed in the presence of KBr-treated serum and of an excess of iodoacetamide-treated Ct2. To achieve a certain degree of hemolysis, only a few C'3 molecules were required per Cr4, 2a site if the Cr4 multiplicity was high. However, if this was low, many more C'3 molecules were necessary. The reciprocal relation between C~3 and C~4 in hemolysis is more clearly demonstrated in Fig. 10 , where it is shown for three different degrees of lysis, namely 12, 18, and 23 %.
DISCUSSION
The experiments described above are part of a comprehensive study which aims at the elucidation of the entire complement reaction mechanism. Previous reports from this laboratory dealt with the mechanism of action of C/4 (14) and with the formation of functionally significant complexes between C~5 and C~6 (6, 32) , and Ct2 and C~4 (30 a). The present work was focused entirely on the reaction mechanism of C'3 in complement-cell interaction.
Three questions were primarily pursued: (a) Which is the complement component that governs the C'3 reaction step? (b) How is Ct3 bound to cells? (c) To what extent does bound C~3 participate in the cytolytic reaction? Two major technical requirements had to be fulfilled to enable this investigation: (a) Detection and estimation of the hemolytic activity of C'3 and; (b) detection of C'3 by a method not based upon its hemolytic activity but upon some other property of the component. The latter method was needed to follow the fate of Ct3 throughout the hemolytic reaction beyond the point where it can be recognized by its activity. It also was to serve for quantitation of Ct3 on a molecular basis and thus to permit establishment of the relation between dose and activity.
Serum treated with KBr became a convenient tool for assaying Ct3 activity. As will be shown elsewhere (20) , KBr inactivates Cr3 and C~4 while leaving intact all other complement factors. To assay cell-bound C~3 one may proceed in a fashion which is analogous to that used for the determination of cell-bound C'2a. EACqa, 4,2a cells are assayed by lysis in the presence of EDTA-serum (33) . Similarly, EACqa,4,2a, 3 cells can be determined by lysis in the presence of EDTA-serum that was previously treated with KBr. KBr-treated serum also proved useful for preparing complement in which C~3 and Ct4 were replaced by known amounts of their radioactively labeled counterparts.
Detection of C'3 and also of C~4 without resort to their hemolytic activity was afforded by means of a radioactive label. A technique was employed utilizing I m and I ~"1 in carrier-free form thus minimizing the risk of loss of biologic activity due to iodination. The hemolytic activity of all labeled preparations employed in this study was carefully compared with that of the original material; in no instance did labeling result in loss of activity. Iodination was carried out such that it resulted in an average specific radioactivity of approximately 50,000 cPM//zg. This afforded the detection of as little as 0.002 #g of C'3 or C'4.
The possibility existed that the C'3 reaction step was governed not only by C~2a, but also by one of the later complement components, e.g., Cr5 or C'6. Some evidence, possibly in favor of such a mechanism, had been obtained by Linscott and Cochrane (25) who worked with guinea pig euglobulin fractions as a source of CP3. To obtain an unequivocal answer, the use of highly purified C'3 was imperative. C'3 devoid of detectable contaminants and, in particular, free of C~5 and C'6 was obtained according to an improved method of isolation which was published recently (6) . Utilizing this material it became apparent that both reactions, binding of C~3 to ceils and conversion of Ct3 to C~3i are effected solely by cell-bound C~2a.
It should be mentioned at this point that C'2a occurs in the form of a proteinprotein complex with C'4. According to unpublished observations made in this laboratory (30 b) , formation of the C'4,2a complex requires the catalytic action of C'1 esterase. C~2 cannot be converted to its hemolytically active form, C'2a, unless it becomes linked to C'4. Thus, "C'2a" always implies that this component is present in form of the activated C'4,2a complex. It is this complex that is actually responsible for the conversion and binding of C~3.
Innumerable observations indicate that for human C'3 there exists an intimate relation between binding to cells and conversion. Binding was never observed to occur without the appearance of the conversion product, C'3i, in the fluid phase. On the other hand, conversion was found to proceed freely in the absence of binding. This was shown by treating serum with C'1 esterase, as was done by Pondman (27) , or by reacting purified C'3 with isolated C~4,2a complex in cell-free solution (30 a and 30 b). It would seem probable, therefore, that binding is always preceded by conversion and that it is only the converted material that is bound. If this concept were correct, bound C'3 should closely resemble converted C'3 in the fluid phase. By physicochemical and immunologic criteria, such resemblance was, indeed, found to exist after detachment of bound C'3 from cell membranes by mild procedures (19) . However, why does C'3i accumulate in the fluid phase during the hemolytic reaction if converted C~3 was capable of being bound to cells? Obviously a third molecular form of Ct3 has to be postulated to reconcile all observations. Fig. 11 illustrates the proposed concept of the mechanism of C~3 binding to the membrane of sheep erythrocytes. When a native C'3 molecule collides with cell-bound CP4,2a complex it is acted upon enzymatically. Cleavage of a critical bond, the nature of which is not yet known, results in "activation" of the molecule which may simply represent a change in conformation. In this acti-vated form the molecule is enabled to react with acceptor groups which occur on the cell surface. In order to become bound, the activated molecule has to transfer from the C'4, 2a complex to membrane sites. Perhaps due to instability of its conformation, activated C'3 has a very short half-life. It tends to convert to C'3i, a molecular form that is stable in conformation, but unable to bind to cell membranes. Under these conditions only a small percentage of activated C'3 molecules are expected to be bound; the rest will be converted to C'3i.
There are two reasons for postulating that the site of binding is different and spacially separated from the site of activation. Such a process would explain (a) the observed accumulation of C'3i in the fluid phase, and (b) the capacity of a single C'4,2a site to mediate the binding of several hundred C'3 molecules. Verification of this concept was sought subsequently through electron microscope studies utilizing ferritin-conjugated antibodies to C'3 and C'4. The results, which will be reported separately (34) , demonstrated clearly that bound C'3 and C'4 molecules were distributed differently and that C'3 may occupy areas of the cell membrane which are completely devoid of C'4.
Little is known regarding the chemical nature of the binding site of C'3 on the cell surface. At first it seemed probable that the antibody molecules which coat sensitized cells serve as receptors. Under appropriate conditions, C~3 and also C'4 establish a firm physical union with antigen-antibody complexes (7) aad with the aid of C'I esterase, C'4 can bind even to unaggregated 7S -/-globulin (14) . Furthermore, Leddy et al. (35) , working with the human cold agglutinin system, found that proteins with the antigenic properties of C'3 and C'4 were carried along with the antibody when the latter was transferred from one cell batch to another. Thus, there is little doubt that CP3 and Ct4 can be bound by ~,-globulin. Nevertheless, in the present study antibody could be ruled out as an essential C'3-receptor. EC'4,2a cells were as efficient in taking up Ct3 as EACh4,2a cells which contained 8 units of rabbit hemolysin. Thus, in analogy to Ct4 (14) , C~3 appears to be capable of combining directly with membrane constituents. That cells containing functionally intact C~2, C~3, and CP4 can be prepared in vitro without using antibody may be pertinent to certain in vivo processes.
In spite of its ability to convert C~3 to C~3i, fluid phase C~4,2a complex (30 b) failed to effect binding of Ct3 to cell receptors. So far, only cell-bound C~4,2a was found to mediate C~3 uptake. The difference between these two situations is the relative proximity of the complex to C~3 binding sites, the cellbound complex being consistently closer to them. The failure of fluid phase C~4,2a to mediate the binding reaction may simply reflect a very short halflife of activated C~3. However, the possibility cannot be ruled out that the bound complex confers a new property upon the surrounding cell surface which facilitates Ct3 binding.
The quantitative data accumulated in this study have shed light on certain aspects of the molecular economy inherent in the hemolytic complement reaction. According to available data, C~3 represents the most abundant of all complement components in human serum; its concentration being approximately 500 to 800 #g/ml (7, 36) . Thus, relative to other complement components, there is a large number of C~3 molecules available for the various reactions of which complement is capable. As demonstrated above, due to the activity of the C'4,2a complex, large numbers of C~3 molecules are, in fact, turned over and bound to cells in immune hemolysis. Are all of these molecules necessary to achieve lysis of a single cell?
According to Mayer (12, 31) a single hit is sufficient to commit a cell to lysis; a hit being the result of a chain reaction involving all the components of complement. Humphrey and Dourmashkin (37) showed that hits result in the formation of holes in the cell membrane and that there is a fairly good correspondence between the number of holes found and the number of hits predicted on the basis of the one-hit theory. One would expect, therefore, to find only one or, perhaps, a very few C'3 molecules bound to a cell (at 64% lysis), but in actual fact, several thousand molecules were found. Emphasis is placed on the observation that the degree of lysis was proportional to the number of C~3 molecules bound, indicating that the encountered C'3 multiplicity is relevant to the outcome of the hemolytic reaction. Therefore, if a single hit is sufficient to cause lysis of a cell, then multiple C~3 sites are required for the occurrence of one hit.
The number of C'3 molecules required for a certain percentage of lysis was ~ rmMOLYSXS
shown to vary inversely with the number of C'4,2a-sites per cell. The significance of this phenomenon is not clear. It might indicate that C'3 must be placed into critical areas on the erythrocyte surface in order to be hemolytically effective and that the probability of this happening increases with the number of Cr4, 2a sites bound per cell. Alternatively, the phenomenon might be related to the postulated joint function of C'3 and the C'4,2a complex in activating CP5 and C%. The mechanism of activation of Ct5 and C% is presently under investigation.
SIYMMARY
During immune hemolysis by human complement, C~3 (~ic-globulin) becomes physically attached to the erythrocyte membrane. Binding of CP3 was found to be mediated by ce11-bound, activated CP2 and to have the characteristics of an enzymatic reaction. A single CP4,2a site on the cell surface effected the binding of several hundred molecules of Ct3 if the latter was provided in excess. The accumulation of hemolyfically inactive, physicochemically altered C~3 in the fluid phase was found to be an inherent feature of the process of C~3 binding. It is postulated that C~4,2a activates C~3 for its subsequent reaction with cell membrane receptors. Antierythrocyte antibody did not play an essential role in CP3 uptake; CP3 could be bound to erythrocyte-C~4,2a complexes which were entirely devoid of antibody.
Ce11-bound C~3 proved hemolytically active, the degree of hemolysis being proportional to the number of C~3 molecules per ce11. Binding of a large number of CP3 molecules per cell was found to be a prerequisite for the production of the immune adherence phenomenon and for immune hemolysis.
